ICU Medical (NASDAQ:ICUI) Upgraded to Buy at StockNews.com

ICU Medical (NASDAQ:ICUI) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday.

A number of other equities research analysts have also weighed in on ICUI. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday, March 12th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, ICU Medical has an average rating of “Buy” and an average target price of $168.67.

ICU Medical Stock Performance

Shares of ICUI opened at $139.32 on Friday. The stock has a 50-day simple moving average of $151.64 and a 200-day simple moving average of $162.55. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical has a 1 year low of $93.36 and a 1 year high of $196.26. The stock has a market capitalization of $3.42 billion, a PE ratio of -30.49 and a beta of 0.73.

Institutional Trading of ICU Medical

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vise Technologies Inc. increased its holdings in shares of ICU Medical by 7.1% in the 4th quarter. Vise Technologies Inc. now owns 2,649 shares of the medical instruments supplier’s stock valued at $411,000 after acquiring an additional 176 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of ICU Medical by 20.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 51,531 shares of the medical instruments supplier’s stock worth $7,996,000 after buying an additional 8,789 shares during the period. Woodline Partners LP grew its holdings in shares of ICU Medical by 4.5% during the fourth quarter. Woodline Partners LP now owns 122,239 shares of the medical instruments supplier’s stock worth $18,968,000 after buying an additional 5,300 shares during the last quarter. Squarepoint Ops LLC acquired a new position in ICU Medical in the 4th quarter valued at about $3,236,000. Finally, Tidal Investments LLC acquired a new stake in ICU Medical during the 4th quarter worth approximately $342,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.